H Zhang1, W Li, S Sun, S Yu, M Zhang, F Zou. 1. Department of Occupational Health and Occupational Medicine, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Abstract
OBJECTIVES: Sphingosine kinase (SphK), which is regulated by hypoxia, catalyses phosphorylation of sphingosine to produce sphingosine-1-phosphate, which stimulates invasiveness of gliomas. However, whether SphK is involved in proliferation of glioma cells under hypoxic conditions is not clearly understood. In this study, we have investigated the role of SphK in of proliferation glioma cells under hypoxia. MATERIALS AND METHODS: Effects of small interfering RNA (siRNA) on SphKs, SKI (inhibitor of SphK) and U0126 (inhibitor of ERK) on proliferation of glioma cells under hypoxia were studied using CCK-8 assay and flow cytometry. Protein expression profiles were evaluated by Western blot analysis. RESULTS: SKI suppressed proliferation of glioma cells under hypoxia. Similarly, downregulation of SphKs by siRNA inhibited glioma cell proliferation, and the cell cycle was arrested in G(2) /M phase when SphK1 was inhibited. In addition, inhibition of SphK1 attenuated phosphorylation of ERK in hypoxic conditions. Furthermore, U0126 markedly inhibited cell population growth and arrested cells in G(2) /M as effectively as SKI. However, silencing SphK2 induced cell cycle arrest in the S phase and it showed little effect on hypoxia-induced activation of ERK. CONCLUSIONS: SphK1 and SphK2 are involved in proliferation of glioma cells in hypoxic conditions through distinct signalling pathways. SphK1, but not SphK2, promotes cell population expansion in hypoxic conditions by activating ERK.
OBJECTIVES:Sphingosine kinase (SphK), which is regulated by hypoxia, catalyses phosphorylation of sphingosine to produce sphingosine-1-phosphate, which stimulates invasiveness of gliomas. However, whether SphK is involved in proliferation of glioma cells under hypoxic conditions is not clearly understood. In this study, we have investigated the role of SphK in of proliferation glioma cells under hypoxia. MATERIALS AND METHODS: Effects of small interfering RNA (siRNA) on SphKs, SKI (inhibitor of SphK) and U0126 (inhibitor of ERK) on proliferation of glioma cells under hypoxia were studied using CCK-8 assay and flow cytometry. Protein expression profiles were evaluated by Western blot analysis. RESULTS:SKI suppressed proliferation of glioma cells under hypoxia. Similarly, downregulation of SphKs by siRNA inhibited glioma cell proliferation, and the cell cycle was arrested in G(2) /M phase when SphK1 was inhibited. In addition, inhibition of SphK1 attenuated phosphorylation of ERK in hypoxic conditions. Furthermore, U0126 markedly inhibited cell population growth and arrested cells in G(2) /M as effectively as SKI. However, silencing SphK2 induced cell cycle arrest in the S phase and it showed little effect on hypoxia-induced activation of ERK. CONCLUSIONS:SphK1 and SphK2 are involved in proliferation of glioma cells in hypoxic conditions through distinct signalling pathways. SphK1, but not SphK2, promotes cell population expansion in hypoxic conditions by activating ERK.
Authors: Lewis R Vann; Shawn G Payne; Lisa C Edsall; Sharon Twitty; Sarah Spiegel; Sheldon Milstien Journal: J Biol Chem Date: 2002-01-28 Impact factor: 5.157
Authors: Poulami Mitra; Carole A Oskeritzian; Shawn G Payne; Michael A Beaven; Sheldon Milstien; Sarah Spiegel Journal: Proc Natl Acad Sci U S A Date: 2006-10-18 Impact factor: 11.205
Authors: Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch Journal: Clin Cancer Res Date: 2004-12-15 Impact factor: 12.531
Authors: James R Van Brocklyn; Catherine A Jackson; Dennis K Pearl; Mark S Kotur; Pamela J Snyder; Thomas W Prior Journal: J Neuropathol Exp Neurol Date: 2005-08 Impact factor: 3.685
Authors: Jiwang Chen; Haiyang Tang; Justin R Sysol; Liliana Moreno-Vinasco; Krystyna M Shioura; Tianji Chen; Irina Gorshkova; Lichun Wang; Long Shuang Huang; Peter V Usatyuk; Saad Sammani; Guofei Zhou; J Usha Raj; Joe G N Garcia; Evgeny Berdyshev; Jason X-J Yuan; Viswanathan Natarajan; Roberto F Machado Journal: Am J Respir Crit Care Med Date: 2014-11-01 Impact factor: 21.405
Authors: Karl Quint; Norbert Stiel; Daniel Neureiter; Hans Ulrich Schlicker; Christopher Nimsky; Matthias Ocker; Herwig Strik; Malgorzata Anna Kolodziej Journal: Tumour Biol Date: 2014-06-06
Authors: Salina Gairhe; Sachindra R Joshi; Mrigendra M Bastola; Jared M McLendon; Masahiko Oka; Karen A Fagan; Ivan F McMurtry Journal: Pulm Circ Date: 2016-09 Impact factor: 3.017
Authors: Jakub Godlewski; Anna M Krichevsky; Mark D Johnson; E Antonio Chiocca; Agnieszka Bronisz Journal: Neuro Oncol Date: 2014-10-09 Impact factor: 12.300
Authors: Elena Riccitelli; Paola Giussani; Clara Di Vito; Giuseppe Condomitti; Cristina Tringali; Manuela Caroli; Rossella Galli; Paola Viani; Laura Riboni Journal: PLoS One Date: 2013-06-24 Impact factor: 3.240
Authors: Aneta Dobierzewska; Macarena Palominos; Marianela Sanchez; Michael Dyhr; Katja Helgert; Pia Venegas-Araneda; Stephen Tong; Sebastian E Illanes Journal: PLoS One Date: 2016-06-10 Impact factor: 3.240